Interim analysis of the clinical performance of five SARS-Cov-2 serology assays.
作者信息
Knauer Michael J, Hedley Benjamin D, Bhayana Vipin, Payne Michael, Chin-Yee Ian, Delport Johan
机构信息
Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada.
Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada.
出版信息
Clin Biochem. 2020 Dec;86:28-30. doi: 10.1016/j.clinbiochem.2020.09.002. Epub 2020 Sep 6.
Abstract
摘要
相似文献
1
Interim analysis of the clinical performance of five SARS-Cov-2 serology assays.五种新型冠状病毒2型血清学检测方法临床性能的中期分析。
Clin Biochem. 2020 Dec;86:28-30. doi: 10.1016/j.clinbiochem.2020.09.002. Epub 2020 Sep 6.
2
SARS-CoV-2 serology testing: Progress and challenges.SARS-CoV-2 血清学检测：进展与挑战。
J Immunol Methods. 2021 Jul;494:113060. doi: 10.1016/j.jim.2021.113060. Epub 2021 Apr 26.
3
Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients.新型冠状病毒肺炎患者恢复期的纵向血清学分析和中和抗体水平。
J Infect Dis. 2021 Feb 13;223(3):389-398. doi: 10.1093/infdis/jiaa659.
4
The complexities of SARS-CoV-2 serology.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）血清学的复杂性。
Lancet Infect Dis. 2020 Dec;20(12):1350-1351. doi: 10.1016/S1473-3099(20)30699-X. Epub 2020 Sep 23.
5
Multiplex assessment of SARS-CoV-2 antibodies improves assay sensitivity and correlation with neutralizing antibodies.多重评估 SARS-CoV-2 抗体可提高检测敏感性，并与中和抗体相关。
Clin Biochem. 2021 Nov;97:54-61. doi: 10.1016/j.clinbiochem.2021.08.006. Epub 2021 Aug 26.
6
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.五种市售血清学检测方法检测 SARS-CoV-2 抗体的性能比较及识别高中和抗体滴度个体。
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02257-20.
7
Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2.商业血清学检测可预测针对 SARS-CoV-2 的中和活性。
Clin Chem. 2021 Jan 30;67(2):404-414. doi: 10.1093/clinchem/hvaa262.
8
Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2.评估针对 SARS-CoV-2 的 IgG 和中和抗体的免疫原性检测方法的稳健验证和性能比较。
PLoS One. 2022 Feb 7;17(2):e0262922. doi: 10.1371/journal.pone.0262922. eCollection 2022.
9
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test.高通量 SARS-CoV-2 血清学检测在轻症 COVID-19 患者纵向队列中的评估：临床敏感性、特异性和与病毒中和试验的关联。
Clin Chem. 2021 Apr 29;67(5):742-752. doi: 10.1093/clinchem/hvaa336.
引用本文的文献
1
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
2
Critically Ill COVID-19 Patients Exhibit Anti-SARS-CoV-2 Serological Responses.危重症 COVID-19 患者表现出抗 SARS-CoV-2 血清学反应。
Pathophysiology. 2021 May 17;28(2):212-223. doi: 10.3390/pathophysiology28020014.
3
Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.基于快速和准确的凝集反应的 SARS-CoV-2 抗体检测。
Cell Rep Methods. 2021 Jun 21;1(2):100011. doi: 10.1016/j.crmeth.2021.100011. Epub 2021 May 12.
4
Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern.针对表位的抗体反应可区分 COVID-19 结局和关注变异株。
JCI Insight. 2021 Jul 8;6(13):e148855. doi: 10.1172/jci.insight.148855.
5
Detection and Profiling of Human Coronavirus Immunoglobulins in Critically Ill Coronavirus Disease 2019 Patients.危重症新型冠状病毒肺炎患者中人类冠状病毒免疫球蛋白的检测与分析
Crit Care Explor. 2021 Mar 12;3(3):e0369. doi: 10.1097/CCE.0000000000000369. eCollection 2021 Mar.
本文引用的文献
1
SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health.严重急性呼吸综合征冠状病毒2（COVID-19）血清学：对临床实践、检验医学和公共卫生的影响
CMAJ. 2020 Aug 24;192(34):E973-E979. doi: 10.1503/cmaj.201588. Epub 2020 Aug 3.
2
Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients.2019年冠状病毒病危重症患者的炎症谱分析
Crit Care Explor. 2020 Jun 22;2(6):e0144. doi: 10.1097/CCE.0000000000000144. eCollection 2020 Jun.
3
Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies.评估六种中高容量抗体商业试剂盒和六种即时侧向流动检测试剂盒用于 SARS-CoV-2 抗体检测。
J Clin Microbiol. 2020 Sep 22;58(10). doi: 10.1128/JCM.01361-20.
4
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.无症状 SARS-CoV-2 感染的临床和免疫学评估。
Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.
5
Antibody Profiles in Mild and Severe Cases of COVID-19.新冠肺炎轻症和重症病例的抗体谱
Clin Chem. 2020 Aug 1;66(8):1102-1104. doi: 10.1093/clinchem/hvaa137.
6
Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.新型冠状病毒特异性 IgA 反应在 COVID-19 患者中的特征。
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.01526-2020. Print 2020 Aug.
7
Antibody responses to SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎（COVID-19）患者的 SARS-CoV-2 抗体反应。
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
8
Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients.基于 COVID-19 患者疾病严重程度的核酸和血清学检测结果的不同纵向模式。
Emerg Microbes Infect. 2020 Dec;9(1):833-836. doi: 10.1080/22221751.2020.1756699.
9
Developing antibody tests for SARS-CoV-2.研发针对新型冠状病毒的抗体检测方法。
Lancet. 2020 Apr 4;395(10230):1101-1102. doi: 10.1016/S0140-6736(20)30788-1.
Zotero 插件